Markets:

Overview

News

Currencies

International

Treasuries

Aptinyx Inc. - Common Stock (NQ:APTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 18, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptinyx Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 16, 2022

Via Benzinga

Preclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for Neuroscience

November 10, 2022

From Aptinyx Inc.

Via Business Wire

Aptinyx Reports Third Quarter 2022 Financial Results and Recent Highlights

November 08, 2022

From Aptinyx Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 07, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Clinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH Grant

November 03, 2022

From Aptinyx Inc.

Via Business Wire

Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

October 18, 2022

From Aptinyx Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 07, 2022

Gainers

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 25, 2022

Via Benzinga

Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies

August 25, 2022

From Aptinyx Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022 ↗

August 16, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Aptinyx ↗

August 15, 2022

Over the past 3 months, 4 analysts have published their opinion on Aptinyx (NASDAQ:APTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 12, 2022

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗

August 12, 2022

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

Via Benzinga

Aptinyx Shares Plummet As Mid-Stage Fibromyalgia Study Missed Primary Endpoint ↗

August 12, 2022

Aptinyx Inc. (NASDAQ: APTX) announced results from a Phase 2b clinical study evaluating the effects of NYX-2925 in patients with fibromyalgia. The Phase 2b clinical study was designed to evaluate the...

Via Benzinga

Here's Why Aptinyx Stock Is Lower By Over 30% Friday ↗

August 12, 2022

Aptinyx Inc (NASDAQ: APTX) shares are trading lower by 35.80% to $0.39 Friday morning after the company announced results from its Phase 2b Study of NYX-2925 did not achieve the primary endpoint. What...

Via Benzinga

Aptinyx's Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study ↗

August 12, 2022

Aptinyx Inc (NASDAQ: APTX) has announced results from a Phase 2b study evaluating the effects of NYX-2925 in patients with fibromyalgia, characterized by muscular or musculoskeletal pain with stiffness...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 12, 2022

Via Benzinga

Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia

August 12, 2022

From Aptinyx Inc.

Via Business Wire

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 08, 2022

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

Aptinyx: Q2 Earnings Insights ↗

August 04, 2022

Aptinyx (NASDAQ:APTX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Aptinyx beat estimated earnings by...

Via Benzinga

Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights

August 04, 2022

From Aptinyx Inc.

Via Business Wire

Aptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022

July 15, 2022

From Aptinyx Inc.

Via Business Wire

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Aptinyx Inc. - Common Stock (NQ:APTX)

All News about Aptinyx Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today